$169/mo
Tirzepatide
Weekly and dual-action. Care, coaching and shipping included.
Get startedHome / Embody alternatives
Embody’s advertised starting prices are among the lowest online, and it includes unlimited appointments. What it doesn’t publish before your assessment is what you’ll pay month to month, or at a higher dose. Here are three alternatives with prices you can see up front, and when staying with Embody makes sense.
Embody vs NexLife
| Provider | All in, to start |
|---|---|
| Embody | From $129 tirzepatide From $79 semaglutide, advertised |
| NexLife | $169 tirzepatide $139 semaglutide |
Takes a few minutes online. A licensed provider decides if treatment is right for you.
4.8 out of 5 on Trustpilot
Your medication and dose, the date of your last dose, and your prescription label or a recent receipt.
They check your history and current dose and, when appropriate, continue it.
The same price at every dose, with care, coaching and shipping included.
NexLife publishes this page and is one of the alternatives on it. That's why every price is sourced, the brand-name options are listed with their prices, and the case for staying with Embody is made in plain words.
If you want a price you can see before you sign up, NexLife is the closest alternative: compounded tirzepatide for $169 a month and semaglutide for $139, all in, published up front and the same at every dose, with no membership. Embody advertises from $129 and $79 a month, but doesn’t say which plan length or dose those prices cover. Paying Embody less than that today? We’ll match your regular all-in monthly price. For brand-name medication with insurance help, look at Ro.
The reasons we hear most, with the numbers behind them.
| Provider | What you get | All in, to start |
|---|---|---|
| Embody (now) | Compounded tirzepatide or semaglutide. No membership; advertised "starting at" prices, with no fixed price by medication before the assessment | From $129 tirzepatide From $79 semaglutide, advertised |
| NexLife | Compounded tirzepatide or semaglutide. No membership; the same price at every dose | $169 tirzepatide $139 semaglutide |
| Mochi | Compounded, with brand-name options. Includes a $79 monthly membership; medication priced by dose | $169 tirzepatide $139 semaglutide, to start |
| Ro | Brand-name Zepbound or Wegovy at the manufacturer's price, plus a $149 monthly membership; rises with the dose | $448 to $598 tirzepatide $348 to $498 semaglutide |
Month-to-month prices from each provider's own website, checked September 24, 2026, memberships included. See the GLP-1 price index for every plan.
Ranked by all-in monthly price, then by what's included.
Compounded tirzepatide at $169 a month and semaglutide at $139, published before you apply and the same at every dose, with no membership. If Embody charges you less, we'll match it. Compounded, so not FDA-approved.
Board-certified obesity medicine doctors you choose, plus registered dietitians. Compounded tirzepatide from $169 and semaglutide from $139 to start, including a $79 monthly membership, with the medication priced by dose.
A concierge checks your coverage for Zepbound or Wegovy and handles the paperwork. Paying cash, it's $448 to $598 a month for Zepbound and $348 to $498 for Wegovy, membership included, rising with the dose.
Switching isn't always the right move. Stay if:
Whatever you choose, a licensed provider should review your history and dose before anything changes.
Keep following your Embody prescription until your new provider confirms your next step.
Your medication and dose, the date of your last dose, and your prescription label or a recent receipt.
A NexLife provider looks at your dose and how you're tolerating it and, when appropriate, continues it.
Moving between brand-name and compounded medication is a change of product. Compounded medication isn't FDA-approved, and your provider will walk you through it.
Paying less than NexLife for compounded medication somewhere else? See how our price match works.
Both are prepared by U.S.-licensed 503A pharmacies, lab-tested batch by batch and shipped free. Your provider helps you decide which one fits.
$169/mo
Weekly and dual-action. Care, coaching and shipping included.
Get started$139/mo
Weekly GLP-1. Care, coaching and shipping included.
Get startedPrescription required. Compounded medications are not FDA-approved. On 12-month plans: $139 a month for tirzepatide, $119 for semaglutide, still the same at every dose.
No membership, no dose surcharges, no surprises. One flat, all-inclusive monthly price at every dose.
| Month one | Month two | Month three | Every month after | |
|---|---|---|---|---|
| Tirzepatide | $169 | $169 | $169 | $169 |
| Semaglutide | $139 | $139 | $139 | $139 |
Month-to-month plan, all-inclusive. Longer plans cost less and stay flat: $159, $149 and $139 a month for tirzepatide on 3-, 6- and 12-month plans; $132, $125 and $119 for semaglutide.
Tap where you are now. We'll show your NexLife price next to it.
Pick one above to see your price.
Prices from each provider's website, checked September 24, 2026. Brand-name and compounded medications are different products; compounded medications are not FDA-approved. †Price match terms apply.
Switching from another provider? If you take compounded tirzepatide or semaglutide somewhere else, we'll match the monthly price you pay today, all in.† You keep your price, and gain a provider who follows your dose, a personal nutrition plan, a 1:1 coaching call and support 24/7.
Switch with confidencePrice matched in writingCancel anytime
†NexLife Price Match Guarantee: for new members switching from a licensed U.S. telehealth provider with an active prescription for compounded tirzepatide or semaglutide. Send a receipt from the last 60 days and we match your regular all-in monthly price (medication plus required fees), not first-month offers or coupons, for as long as your membership stays active. A NexLife provider must determine that treatment is right for you. Full terms.
If you want a price you can see before you sign up, NexLife is the closest alternative: compounded tirzepatide for $169 a month and semaglutide for $139, all in, published up front and the same at every dose, with no membership. Embody advertises from $129 and $79 a month, but doesn’t say which plan length or dose those prices cover. Paying Embody less than that today? We’ll match your regular all-in monthly price. For brand-name medication with insurance help, look at Ro.
It depends on what Embody quotes you. Embody advertises compounded tirzepatide from $129 a month and semaglutide from $79, but doesn’t say which plan length or dose those prices cover, or what month to month costs. NexLife’s price is published: $169 and $139 a month, month to month, the same at every dose. If you pay Embody less as your regular all-in monthly price, we’ll match it.
Embody advertises compounded tirzepatide from $129 a month and semaglutide from $79, and its site says there’s no membership or hidden fees. It doesn’t publish a fixed price by medication before the assessment, or its prices at higher doses, as of September 24, 2026.
Its site says there’s no membership or hidden fees, as of September 24, 2026. NexLife has no membership either.
Often, yes. With proof of your current prescription and dose, a NexLife provider can review it and, when appropriate, continue you at that dose at the same flat price.
Yes. If you pay Embody less for compounded tirzepatide or semaglutide than NexLife’s price, send a receipt from the last 60 days and we’ll match your regular all-in monthly price for as long as your NexLife membership stays active. First-month offers and coupons don’t count, and a NexLife provider must determine that treatment is right for you.
Both programs prescribe compounded medication, and neither product is FDA-approved. At NexLife, U.S.-licensed 503A pharmacies prepare it and every batch is lab-tested.
Ro prescribes brand-name Zepbound and Wegovy, from $448 and $348 a month all in, with a concierge that checks your insurance. Hims does too, from $448 and $298. Mochi lists brand-name options alongside its compounded programs.
No. A licensed provider reviews your health history and prescribes only if treatment is appropriate for you. Not everyone who applies is prescribed, and that's how it should be.
Compounded tirzepatide and semaglutide are not FDA-approved. The FDA has not reviewed them for safety, effectiveness or quality. The risks below come from the labeling of the FDA-approved medicines.
Both medicines may cause tumors in the thyroid, including thyroid cancer. In studies with rodents they caused thyroid tumors, and it isn't known whether they cause them in people. Don't use either if you or anyone in your family has had medullary thyroid carcinoma (MTC), or if you have multiple endocrine neoplasia syndrome type 2 (MEN 2). Tell your clinician if you notice a lump or swelling in your neck, hoarseness, trouble swallowing or shortness of breath.
Serious side effects can include inflammation of the pancreas (pancreatitis), gallbladder problems, low blood sugar (especially with insulin or sulfonylureas), kidney problems from dehydration, severe stomach problems, serious allergic reactions, vision changes in people with type 2 diabetes, and depression or thoughts of suicide. Tell your care team before any surgery or procedure that uses anesthesia or deep sedation. Don't combine either medicine with other GLP-1 medicines.
Tirzepatide can make birth control pills less effective: use another method for 4 weeks after you start and after each dose increase. Semaglutide should be stopped at least 2 months before a planned pregnancy. Tell your clinician if you're pregnant, planning to be, or breastfeeding.
This is a summary, not the complete safety information. Read the full Prescribing Information for FDA-approved tirzepatide (Zepbound) and semaglutide (Wegovy), and talk with your clinician. You can report side effects to the FDA at 1-800-FDA-1088 or fda.gov/medwatch.
A comparison is only as good as the people who stand behind it. Here's who checked this page, and the rules we hold ourselves to.
Medically reviewed this page on September 24, 2026.
Checked every provider's own pricing page on September 24, 2026. Sources are linked at the bottom of this page.
Start with a few minutes online. A licensed provider reviews your current dose and history and takes it from there.
A short online health assessment. It takes a few minutes.
You're prescribed only if treatment is right for you.
Free expedited shipping, typically 1 to 2 business days, and 24/7 support from there.
The facts in one place, as of September 24, 2026.
More from NexLife: Hims alternatives · Ro alternatives · Mochi alternatives · best tirzepatide providers · best semaglutide providers · switching providers, price matched
Physician-led, LegitScript-certified telehealth for GLP-1 weight loss. One flat price at every dose, and support 24/7.
© 2026 NexLife. Prescription treatment requires an online evaluation by a licensed provider, and not everyone qualifies. Compounded medications are not FDA-approved. This site does not provide medical advice.